Crystalline forms of fused amino pyridines as hsp90 inhibitors
NZ602271A
Bicyclic compounds and their uses as dual c-src / jak inhibitors
EP2303229A1
Concentrated oxaliplatin solution and its method of preparation
US2009247754A1
Method of preparing huperzine a and derivatives thereof
WO2009056966A1
Near full-genome assay of hcv drug resistance
WO2009098533A1
Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
AU2008204344A1
Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular dystrophy
JP2006273870A
Method for combined administration of anticancer agents, and anticancer agent which enables combined administration
EP1853296A1
Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events
MX2007003387A
Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin.
WO2005063276A1
Methods and compositions using gonadotropin hormone releasing hormone
CN1780634A
Methods and compositions using gonadotropin hormone releasing hormone
CA2490562A1
Implant inserting device
WO03062431A2
Production of epi-hne-4 comprising reduction of improperly processed form
WO03004505A1
Oxaliplatin active substance with a very low content of oxalic acid
